Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES

News Daily News

CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES

Michael O'Riordan

July 22, 2022

CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial

News Conference News EuroPCR 2022

CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial

Yael L. Maxwell

May 24, 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

News Daily News

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

Michael O'Riordan

April 25, 2022

Top Trials of the Past Year: Advanced Revascularization

Presentation ARCH 2022

Top Trials of the Past Year: Advanced Revascularization

Presenter: David G. Rizik

April 23, 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

Female-Specific Data Lacking for Myocardial Revascularization: SCAI

News Daily News

Female-Specific Data Lacking for Myocardial Revascularization: SCAI

February 08, 2022

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.